C2i Genomics Raises $100 Million To Commercialize the Detection of Tiny Traces of Cancer Using AI and Whole Genome Sequencing
Similar Posts
Kentucky Falling Short on Cancer-Fighting Policies
Kentucky Still Has a Long Way to Go When It Comes to Preventing Cancer. Unfortunately, Kentucky is #1 in…
First Databank Announces Partnership with RxCap for Medication Adherence Mobile App
RxCap’s new consumer app will feature reminders, an adherence tracker and FDB Meducation® content, offering patients digital access to their medication…
CloudMedx Inc. and Sutter Physician Services Create Clinical Collaboration
Data sharing, analysis, and outreach to support patient health outcomes CloudMedx Inc. and Sutter Physician Services (SPS) announce a…
